Corbus Pharmaceutical Holdings, Inc. (CRBP)

[stockguard]

Found on Yahoo message board and is a good question:

Question:

"a synthetic oral endocannabinoid-mimetic" Why use a company concentrating on a synthetic version?

Answer:

In general a synthetic is prue so the FDA would have no problems given the green light on a product derived from an cannabinoid-mimetic, yet it will be hard for the FDA to pass any trial that uses a marijuana derived biotech base as it is illegal still in most of the world. Also from my understanding it works the same as THC without the psychoactive constituent of cannabis.